Description
Anti-TNFRSF8 (Brentuximab) -VC-PAB-MMAE ADC | ADC-W-465 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an Anti-TNFRSF8 antibody (Brentuximab) conjugated via a VC-PAB linker to MMAE
Status: In stock
Expected Delivery Time: 9-11Weeks